Diagnostic Performance of a Novel Lipoarabinomannan.

Launched by MÉDECINS SANS FRONTIÈRES, KENYA · Aug 30, 2021

Keywords

ClinConnect Summary

The study aims to assess the performance of a new test called the Fujifilm SILVAMP TB LAM or simply the Fuji-LAM test. The Fuji-LAM test is a test that can be done on urine to look for specific proteins that are produced by the bacteria that causes tuberculosis. This test offers an advantage over the tests that are based on phlegm because most patients can produce urine for testing even when they are very sick. Additionally, this test does not require a complex laboratory set up and it can therefore be used by health workers as they interact with the patient. This study will also look at ho...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 15 years of age or older
• • HIV-positive Group 1: At least one symptom of TB
• Group 2:
• • Advanced HIV disease (CD4 count less than 200cell/µl or clinical stage III/IV)
• • No signs and symptoms of TB
• • Signature of the informed consent
• Exclusion Criteria:
• • Intake of anti-tuberculosis drugs for more than 5 days in the month prior to the consultation except preventive TB treatment.
• • Decline to sign informed consent.